Mercator Medical SA
Mercator Medical EU Taxonomy Data Preview
In 2024, Mercator Medical was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Mercator Medical has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Mercator Medical are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Turnover | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Eligible A Turnover | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Non-Eligible B Turnover | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Opex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Eligible A Opex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Non-Eligible B Opex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Capex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Eligible A Capex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Taxonomy Non-Eligible B Capex | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected EU Taxonomy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Mercator Medical's Revenues from Sustainable Activities
In 2024, Mercator Medical reported EU Taxonomy-eligible revenues of PLN 690,000, representing 0.11% of its total turnover. Of this amount, PLN 360,000 of Mercator Medical's revenues was classified as EU Taxonomy-aligned, indicating that 0.06% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
Mercator Medical's Taxonomy-Eligible Turnover Over Time
- Total Taxonomy Aligned A1 Turnover
- Total Taxonomy Eligible but Not Aligned A2 Turnover
Have Mercator Medical's revenues become more sustainable over time?
Since 2022, Mercator Medical's taxonomy-aligned revenues decreased by 45.45% , indicating a long-term decline in environmentally sustainable revenue performance.
Compared to the previous year (2023), Mercator Medical's taxonomy-aligned revenues decreased by 25% , suggesting that Mercator Medical may have deprioritized sustainable activities, shifted focus away from green offerings, or reduced transparency in its EU Taxonomy reporting.
How much of Mercator Medical's revenue is eligible under the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 690,000 of its revenue was eligible under the EU Taxonomy, representing 0.11% of the company's total turnover. Of this amount, PLN 360,000 (0.06% of total revenue) was classified as Taxonomy-aligned. This means that 0.05% of Mercator Medical's revenue is eligible but not aligned, indicating that these activities did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards.
How much of Mercator Medical's eligible revenue is aligned with the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 360,000 of its revenue was aligned under the EU Taxonomy, representing 0.06% of its total turnover.
This low alignment highlights either a limited focus on green activities or early-stage adoption of sustainability frameworks, underscoring opportunities for further alignment with EU climate objectives.
Mercator Medical's Eligibility & Alignment Overview
Mercator Medical's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Turnover
- Total Taxonomy Eligible but Not Aligned A2 Turnover
How is Mercator Medical's taxonomy-aligned revenue distributed across the EU environmental objectives?
In 2024, Mercator Medical reported that its taxonomy-aligned revenue was distributed across the following EU environmental objectives:
- Climate Change Mitigation: 0.06%
- Climate Change Adaptation: 0%
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 0%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much revenue does Mercator Medical earn from selling climate-related solutions ?
In 2024, Mercator Medical reported that PLN 369,360 of its total revenue was associated with activities contributing to the EU taxonomy climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This accounted for 0.06% of the company's total revenue, indicating that Mercator Medical has limited exposure on solutions that support climate action through its commercial activities.
Insights into Mercator Medical's CAPEX from Sustainable Activities
In 2024, Mercator Medical reported EU Taxonomy-eligible CAPEX of PLN 8.91 million, representing 51.54% of its total CAPEX. Of this amount, PLN 8.28 million of Mercator Medical's CAPEX was classified as EU Taxonomy-aligned, indicating that 47.9% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
Mercator Medical's Taxonomy-Eligible Capex Over Time
- Total Taxonomy Aligned A1 Capex
- Total Taxonomy Eligible but Not Aligned A2 Capex
Have Mercator Medical's increased its investment in sustainable activities over time?
Compared to the previous year (2023), Mercator Medical's taxonomy-aligned CAPEX increased by 83.31%, highlighting Mercator Medical's strengthened commitment to investing in environmentally sustainable activities or improving how such investments are classified and reported under the EU Taxonomy.
How much of Mercator Medical's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 8.91 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 51.54% of the company's total CAPEX. Of this amount, PLN 8.28 million (47.9% of total CAPEX) was classified as Taxonomy-aligned. This means that 3.63% of Mercator Medical's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).
How much of Mercator Medical's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 8.28 million of its CAPEX was aligned under the EU Taxonomy, representing 47.9% of its total capital investment.
This moderate level of alignment indicates that Mercator Medical is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Mercator Medical's Eligibility & Alignment Overview
Mercator Medical's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Capex
- Total Taxonomy Eligible but Not Aligned A2 Capex
How is Mercator Medical's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Mercator Medical reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectives:
- Climate Change Mitigation: 43.27%
- Climate Change Adaptation: 4.63%
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 0%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much Mercator Medical is investing in climate-related solutions?
In 2024, Mercator Medical allocated PLN 8.28 million of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 47.9% of the company's total capital expenditure, indicating that Mercator Medical is moderately allocating capital toward climate-aligned initiatives, while maintaining a diversified investment portfolio.
Insights into Mercator Medical's OPEX from Sustainable Activities
In 2024, Mercator Medical reported EU Taxonomy-eligible OPEX of PLN 6.34 million, representing 68.15% of its total operating expenses (OPEX). Of this amount, PLN 5.31 million of Mercator Medical's OPEX was classified as EU Taxonomy-aligned, indicating that 57.04% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
Mercator Medical's Taxonomy-Eligible Opex Over Time
- Total Taxonomy Aligned A1 Opex
- Total Taxonomy Eligible but Not Aligned A2 Opex
Have Mercator Medical's increased its spending in sustainable activities over time?
Since 2022, Mercator Medical's taxonomy-aligned operating expenditure (OPEX) increased by 173.7%, pointing to a long-term trend of increased spending on environmentally sustainable operations and services recognized under the EU Taxonomy.
Compared to the previous year (2023), Mercator Medical's taxonomy-aligned OPEX increased by 35.52%, highlighting Mercator Medical's growing commitment to funding sustainable operations or improving how such expenses are classified and reported under the EU Taxonomy.
How much of Mercator Medical's operational expenditure (OPEX) is eligible under the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 6.34 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 68.15% of the company's total OPEX. Of this amount, PLN 5.31 million (57.04% of total OPEX) was classified as Taxonomy-aligned. This means that 11.11% of Mercator Medical's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).
How much of Mercator Medical's eligible OPEX is aligned with the EU Taxonomy?
In 2024, Mercator Medical reported that PLN 5.31 million of its OPEX was aligned under the EU Taxonomy, representing 57.04% of its total operational expenditure.
This strong alignment suggests that Mercator Medical is allocating a significant share of its operating budget to environmentally sustainable activities, signaling a strategic emphasis on day-to-day sustainability performance.
Mercator Medical's Eligibility & Alignment Overview
Mercator Medical's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Opex
- Total Taxonomy Eligible but Not Aligned A2 Opex
How is Mercator Medical's taxonomy-aligned OPEX distributed across the EU environmental objectives?
In 2024, Mercator Medical reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectives:
- Climate Change Mitigation: 8.16%
- Climate Change Adaptation: 48.88%
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 0%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much of Mercator Medical's operational budget supports climate-related solutions?
In 2024, Mercator Medical allocated PLN 5.31 million of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 57.04% of the company's total OPEX, indicating that Mercator Medical is focusing a significant share of its operational spending on supporting climate action through its day-to-day activities.